ixazomib
Ligand Summary
an oral proteasome inhibitor with antineoplastic activity; MLN2238 is the biologically active form of MLN9708
UNII: 71050168A2
PubChem: 25183872
Guide to Pharmacology: 8450
ChEMBL: CHEMBL2141296
DrugCentral: 5067
LyCHI: S5QJM63MCSGP
Target Activities
10 Activities
Items per page:
10
1 – 10 of 10
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | INHIBITOR | |||||